
The visceral and subcutaneous abdominal zzso tissue zzso areas and the subcutaneous hip AT area were assessed by magnetic resonance imaging zzso in relation to serum zzso and plasma insulin levels in 12 growth zzso zzso adults before and after 6 months of replacement therapy with zzso human growth hormone zzso and in 12 healthy control zzso Compared with control subjects, zzso patients had a significantly increased amount of visceral zzso which was zzso related with plasma HDL cholesterol and positively correlated with plasma zzso zzso zzso AT was not associated with plasma total and LDL cholesterol or plasma insulin zzso zzso patients also had elevated serum total cholesterol, LDL cholesterol, and zzso levels compared with control zzso After 6 months of zzso replacement therapy the mean zzso subcutaneous zzso and subcutaneous hip AT areas and serum concentration of total cholesterol decreased significantly, whereas serum HDL cholesterol concentration increased zzso No significant correlations were found between changes in the amount of AT and changes in serum zzso and plasma insulin zzso 

